Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CA 4. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel two-step synthesis reduces waste and cost for pharmaceutical intermediates. High purity and scalable production capabilities for global supply chains.
Novel copper complex synthesis offers enhanced antitumor activity and scalable manufacturing processes for global pharmaceutical supply chains.
Patent CN112979648B details a novel Rh-catalyzed synthesis of gamma-carboline derivatives. This method offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel synthetic route for tea geometrid pheromone component offering cost-effective scale-up and high purity for agrochemical applications globally.
Patent CN103288804A reveals a streamlined one-step condensation for Nilotinib, offering superior atom economy and simplified supply chains for API manufacturers.
Patent CN102584675B reveals a mild, high-yield route for 2-bromo-3-arylmercaptoindoles. Discover cost-effective manufacturing and scalable supply chain solutions for antibacterial intermediates.
Patent CN106701698B reveals high-efficiency SsCR enzyme for chiral alcohol synthesis. Achieves 99.9% ee and 500mmol/L substrate concentration for scalable manufacturing.
Patent CN103214487A reveals stable synthesis route. Offers cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Novel synthesis route for high-purity pharmaceutical intermediates. Reduces steps and improves yield for commercial scale-up.
Patent CN1115343C details a novel enzymatic route for chiral cyclopentene amines, offering cost-effective API intermediate manufacturing with high enantiomeric purity.
Patent CN115286559B reveals a three-step route for Paxlovid key intermediate offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN108409626A details a novel route for Rucaparib intermediates offering enhanced purity and cost efficiency for global pharmaceutical supply chains.
Patent CN121202794A reveals a novel two-step synthesis for Azilsartan isomer impurities ensuring high purity and supply chain stability for global pharmaceutical manufacturers.
Patent CN106810452B details a novel zinc amalgam reduction route for cinacalcet hydrochloride. This method ensures high purity, safety, and cost-effective commercial scale-up for global supply chains.
Novel visible light method for deuterated aromatics using arylthianthrene salts. Metal-free, high yield, cost-effective for pharma intermediates.
Novel synthesis route for chiral pyrrolo-pyridine intermediates offers high purity and scalability. Enhances supply chain reliability and reduces manufacturing complexity for global buyers.
Metal-free Brønsted acid catalyzed synthesis of trans-3,4-diaryl dihydrocoumarins with high diastereoselectivity. Ideal for scalable API intermediate manufacturing.
Novel NHPI catalyzed process for Entecavir intermediates offers high yield and scalability for reliable pharmaceutical intermediates supplier partnerships.
Patent CN100473640C details a novel resolution method for trans-2,3-diamino-1,2,3,4-tetrahydronaphthalene using tartaric acid derivatives, offering high ee values and scalable manufacturing.
Patent CN101440068A details a novel 4-step synthesis for high-purity triazole intermediates, offering significant cost reduction and scalable manufacturing for global pharmaceutical supply chains.